Table 5 Characteristics of “adaptive” or “non-adaptive” patients
Characteristics | Adaptive patients | Non-adaptive patients | p-value |
|---|---|---|---|
(n = 101) | (n = 28) | ||
No. (%) | No. (%) | ||
Age (years) | |||
Median (range) | 65 (24–86) | 67 (34–94) | 0.09 |
Sex | |||
Male | 51 (50) | 17 (61) | 0.34 |
Female | 50 (50) | 11 (39) | |
ECOG PS | |||
0 | 8 (8) | 1 (4) | |
1 | 56 (55) | 12 (43) | |
2 | 32 (32) | 12 (43) | |
3 | 4 (4) | 3 (11) | |
4 | 1 (1) | 0 (0) | |
0–1 | 64 (63) | 13 (46) | 0.11 |
2–4 | 37 (37) | 15 (54) | |
Disease status | |||
Advanced | 92 (91) | 28 (100) | 0.10 |
Recurrent | 9 (9) | 0 (0) | |
Primary site | |||
Stomach | 97 (96) | 26 (93) | 0.48 |
GEJ | 4 (4) | 2 (7) | |
No. of metastatic sites | |||
1–2 | 81 (80) | 19 (68) | 0.17 |
> 3 | 20 (20) | 9 (32) | |
Subtype of SPM | |||
Massive ascites | 46 (45) | 16 (57) | 0.50 |
Inadequate oral intake | 28 (27) | 7 (25) | |
Both | 27 (27) | 5 (18) | |
Serum albumin level (g/ml) | |||
Median (range) | 3.1 (1.8–4.4) | 2.9 (2.0–4.2) | 0.13 |
Serum CRP level (mg/dl) | |||
Median (range) | 1.6 (0.0–20.7) | 4.8 (0.1–24.0) | < 0.01 |